Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Identification of ADAM12 as a Novel Basigin Sheddase

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Disorders of Sex Development-Novel Regulators, Impacts on Fertility, and Options for Fertility Preservation

    Research output: Contribution to journalReviewResearchpeer-review

  2. Blood Metabolite Signatures of Metabolic Syndrome in Two Cross-Cultural Older Adult Cohorts

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Neonatal HDL counteracts placental vascular inflammation via S1P-S1PR1 axis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Fluorescent Analogues of Human α-Calcitonin Gene-Related Peptide with Potent Vasodilator Activity

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects with Hepatic Steatosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Glucagon receptor signaling is not required for N-carbamoyl glutamate- and l-citrulline-induced ureagenesis in mice

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The transmembrane glycoprotein basigin, a member of the immunoglobulin superfamily, stimulates matrix metalloproteinase (MMP)-mediated extracellular matrix (ECM) degradation and thereby drives cancer cell invasion. Basigin is proteolytically shed from the cell surface and high concentrations of soluble basigin in the blood dictates poor prognosis in cancer patients. A positive correlation between basigin and a disintegrin and metalloproteinase (ADAM)-12 in serum from prostate cancer patients has been reported. Yet, the functional relevance of this correlation is unknown. Here, we show that ADAM12 interacts with basigin and cleaves it in the juxtamembrane region. Specifically, overexpression of ADAM12 increases ectodomain shedding of an alkaline phosphatase-tagged basigin reporter protein from the cell surface. Moreover, CRISPR/Cas9-mediated knockout of ADAM12 in human HeLa carcinoma cells results in reduced shedding of the basigin reporter, which can be rescued by ADAM12 re-expression. We detected endogenous basigin fragments, corresponding to the expected size of the ADAM12-generated ectodomain, in conditioned media from ADAM12 expressing cancer cell-lines, as well as serum samples from a healthy pregnant donor and five bladder cancer patients, known to contain high ADAM12 levels. Supporting the cancer relevance of our findings, we identified several cancer-associated mutations in the basigin membrane proximal region. Subsequent in vitro expression showed that some of these mutants are more prone to ADAM12-mediated shedding and that the shed ectodomain can enhance gelatin degradation by cancer cells. In conclusion, we identified ADAM12 as a novel basigin sheddase with a potential implication in cancer.

Original languageEnglish
Article number1957
JournalInternational Journal of Molecular Sciences
Volume20
Issue number8
ISSN1661-6596
DOIs
Publication statusPublished - 22 Apr 2019

    Research areas

  • ADAM12 Protein/chemistry, Amino Acid Sequence, Basigin/chemistry, CRISPR-Cas Systems, Cell Line, Gene Expression, Gene Knockdown Techniques, Genes, Reporter, Humans, Mutation, Substrate Specificity

ID: 58217877